Samuel J. Klempner
Massachusetts General Hospital(US)Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
Gastric Cancer Management and Outcomes, Colorectal Cancer Treatments and Studies, Cancer Immunotherapy and Biomarkers, Gastrointestinal Tumor Research and Treatment, Immunotherapy and Immune Responses
Most-Cited Works
- → Gastric Cancer, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology(2022)1,640 cited
- → Tumor mutational burden is predictive of response to immune checkpoint inhibitors in MSI-high metastatic colorectal cancer(2019)622 cited
- → Clinical Acquired Resistance to KRASG12C Inhibition through a Novel KRAS Switch-II Pocket Mutation and Polyclonal Alterations Converging on RAS–MAPK Reactivation(2021)486 cited
- → Esophageal and Esophagogastric Junction Cancers, Version 2.2023, NCCN Clinical Practice Guidelines in Oncology(2023)466 cited
- → Adagrasib with or without Cetuximab in Colorectal Cancer with Mutated KRAS G12C(2022)447 cited
- → Tumor Mutational Burden as a Predictive Biomarker for Response to Immune Checkpoint Inhibitors: A Review of Current Evidence(2019)399 cited